<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:atom="http://www.w3.org/2005/Atom" version="2.0">
  <channel>
    <title>oncology</title>
    <link>https://pitchbook.com/tag/oncology</link>
    <description>oncology</description>
    <language>en-US</language>
    <lastBuildDate>Mon, 09 Sep 2024 20:36:47 GMT</lastBuildDate>
    <atom:link href="https://pitchbook.com/tag/oncology.rss" type="application/rss+xml" rel="self" />
    <item>
      <title>Candid Therapeutics launches with $370M and a pair of acquisitions</title>
      <link>https://pitchbook.com/news/articles/candid-therapeutics-launches-370-million-biopharma</link>
      <description>The startup focuses on hard-to-treat autoimmune disorders.</description>
      <pubDate>Mon, 09 Sep 2024 20:36:47 GMT</pubDate>
      <guid>https://pitchbook.com/news/articles/candid-therapeutics-launches-370-million-biopharma</guid>
    </item>
    <item>
      <title>Moderna hits $7.6B in upsized debut [datagraphic]</title>
      <link>https://pitchbook.com/news/articles/moderna-hits-76b-in-upsized-debut</link>
      <description>The biotech has priced its IPO at $23 per share, raising roughly $604 million. We've put together a datagraphic of the company's financials, key shareholders, valuation history and more.</description>
      <pubDate>Thu, 06 Dec 2018 00:00:00 GMT</pubDate>
      <guid>https://pitchbook.com/news/articles/moderna-hits-76b-in-upsized-debut</guid>
    </item>
  </channel>
</rss>
